Precision measurement company Mettler-Toledo (NYSE: MTD) beat Wall Street’s revenue expectations in Q3 2026, with revenue up 6.3% year on year to $1.09 billion. Its non-GAAP profit of $12.57 per share was 3.9% above analysts’ consensus estimates.
For more on Mettler-Toledo, read our free full research report.
Mettler-Toledo (MTD) Q3 2026 highlights:
- Revenue $1.09 billion vs S&P analysts’ consensus estimates of $1.07 billion (6.3% year-on-year growth, 2% beat)
- Adjusted EPS $12.57 vs S&P analysts’ consensus estimates of $12.09 (3.9% beat)
- Adjusted EPS guidance Management raised its full-year adjusted EPS guidance to $53 at the midpoint, a 12% increase
- Free cash flow margin 25.7%, similar to the same quarter last year
- Organic revenue rose 6% year on year (beat)
- Market capitalization $34.53 billion
Patrick Kaltenbach, President and Chief Executive Officer, stated, “We delivered an excellent third quarter, achieving relatively broad-based growth across our portfolio while capitalizing on improving market demand. Performance was particularly strong in Asia / Rest of World. Improved sales volume and strong execution of our strategic initiatives resulted in another quarter of robust growth in Adjusted EPS.”
Revenue growth
Reviewing a company’s long-term revenue performance reveals insights into its quality. Any business can deliver a good quarter or two, but many enduring ones grow for years. Over the last five years, Mettler-Toledo grew its revenue at a tepid 3% compounded annual growth rate, falling short of the healthcare sector benchmark.
Long-term growth matters most, but within healthcare, a half-decade historical view may miss recent innovations or disruptive industry trends. Mettler-Toledo’s annualized revenue growth of 5.6% over the last two years is above its five-year trend, a positive sign. 
Analyzing the company’s organic revenue helps explain its revenue dynamics by stripping out one-time events like acquisitions and currency fluctuations that don’t accurately reflect its fundamentals. Over the last two years, Mettler-Toledo’s organic revenue averaged 4.5% year-on-year growth. This was in line with its two-year revenue growth, indicating that core operations, rather than acquisitions and divestitures, drove most of its results. 
This quarter, Mettler-Toledo reported year-on-year revenue growth of 6.3%, and its $1.09 billion of revenue exceeded Wall Street’s consensus estimates by 2%.
Looking ahead, sell-side analysts expect revenue to grow 4.5% over the next 12 months, according to S&P, similar to its two-year rate. This uninspiring projection suggests its products and services will face some demand challenges.
Operating margin
Mettler-Toledo has been an efficient company over the last five years. It was one of the more profitable businesses in the healthcare sector, with an average operating margin of 28.4%.
Mettler-Toledo’s operating margin rose by 1.2 percentage points over the last five years, as its revenue growth gave it operating leverage.
in line with the same quarter last year. This indicates the company’s overall cost structure has been relatively stable.
Earnings per share
Revenue trends explain a company’s historical growth, but the long-term change in earnings per share, or EPS, points to the profitability of that growth. For example, a company could inflate its revenue through excessive spending on advertising and promotions.
Mettler-Toledo’s EPS grew at a 7.2% compounded annual growth rate over the last five years, higher than its 3% annualized revenue growth. This indicates the company became more profitable on a per-share basis as it expanded.
A closer look at Mettler-Toledo’s earnings helps explain its performance. As mentioned earlier, Mettler-Toledo’s operating margin expanded by 1.2 percentage points over the last five years. In addition, its share count shrank by 14.4%. These are positive signs for shareholders because improving profitability and share buybacks boost EPS growth relative to revenue growth. 
In Q3, Mettler-Toledo reported adjusted EPS of $12.57, up from $11.15 in the same quarter last year. This result beat analysts’ consensus estimates by 3.9%. Over the next 12 months, Wall Street expects Mettler-Toledo’s full-year EPS to grow 8.9% from $46.30 to $50.40, according to S&P.
Key takeaways from Mettler-Toledo’s Q3 results
Mettler-Toledo’s full-year EPS guidance came in well above analysts’ consensus estimates, and organic revenue also topped Wall Street’s consensus. Those were clear positives in a solid Q3 report. Shares remained flat at $1,679 immediately after the results.
Mettler-Toledo may have had a good quarter, but that alone does not determine whether the stock is a buy. The latest quarter matters, but not nearly as much as longer-term fundamentals and valuation when making that decision. Read our full research report here (it’s free).
